S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

TARS Tarsus Pharmaceuticals Inc

53.00

-2.24 (-4.06%)

Jan 10 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

November 13, 2024 Katherine Goodrich

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Tarsus Pharmaceuticals Charts.

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Tarsus Pharmaceuticals Charts.

Tarsus Pharmaceuticals Inc News

Form 8-K - Current report
Thursday 19 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
Wednesday 6 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 5 November 2024 (2 months ago) • Edgar (US Regulatory)

More Tarsus Pharmaceuticals Inc News Articles

North Bay Resources (PK)

Mullen Automotive

Impact Fusion (PK)

Lightwave Logic

Rennova Health (CE)

Intergrated Cannabis Sol... (PK)

Moon Equity (PK)

Valiant Eagle (PK)

GBT Technologies (PK)

RespireRx Pharmaceuticals (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions